Lundy SK - Search Results

1

CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Vonberg AD, Acevedo-Calado M, Cox AR, Pietropaolo SL, Gianani R, Lundy SK, Pietropaolo M. Vonberg AD, et al. Among authors: lundy sk. JCI Insight. 2018 Dec 6;3(23):e99860. doi: 10.1172/jci.insight.99860. JCI Insight. 2018. PMID: 30518692 Free PMC article.

2

Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice.

Nandedkar-Kulkarni N, Esakov E, Gregg B, Atkinson MA, Rogers DG, Horner JD, Singer K, Lundy SK, Felton JL, Al-Huniti T, Kalinoski AN, Morran MP, Gupta NK, Bretz JD, Balaji S, Chen T, McInerney MF. Nandedkar-Kulkarni N, et al. Among authors: lundy sk. J Immunol. 2021 Apr 1;206(7):1443-1453. doi: 10.4049/jimmunol.1900357. Epub 2021 Mar 3. J Immunol. 2021. PMID: 33658296 Free PMC article.

3

Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.

Wu Q, Mills EA, Wang Q, Dowling CA, Fisher C, Kirch B, Lundy SK, Fox DA, Mao-Draayer Y; AMS04 Study Group. Wu Q, et al. Among authors: lundy sk. JCI Insight. 2020 Feb 13;5(3):e134251. doi: 10.1172/jci.insight.134251. JCI Insight. 2020. PMID: 31935197 Free PMC article.

4

Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes.

Lundy SK, Taitano SH, van der Vlugt LEPM. Lundy SK, et al. Methods Mol Biol. 2021;2270:149-178. doi: 10.1007/978-1-0716-1237-8_9. Methods Mol Biol. 2021. PMID: 33479898

5

Characterization and activity of Fas ligand producing CD5⁺ B cells.

Lundy SK, Klinker MW. Lundy SK, et al. Methods Mol Biol. 2014;1190:81-102. doi: 10.1007/978-1-4939-1161-5_7. Methods Mol Biol. 2014. PMID: 25015275

6

Differential Influence on Regulatory B Cells by T_H2 Cytokines Affects Protection in Allergic Airway Disease.

Taitano SH, van der Vlugt LEPM, Shea MM, Yang J, Lukacs NW, Lundy SK. Taitano SH, et al. Among authors: lundy sk. J Immunol. 2018 Oct 1;201(7):1865-1874. doi: 10.4049/jimmunol.1800206. Epub 2018 Aug 20. J Immunol. 2018. PMID: 30127086 Free PMC article.

7

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.

Xia Y, Tao H, Hu Y, Chen Q, Chen X, Xia L, Zhou L, Wang Y, Bao Y, Huang S, Ren X, Lundy SK, Dai F, Li Q, Chang AE. Xia Y, et al. Among authors: lundy sk. Oncotarget. 2016 Sep 13;7(37):60461-60474. doi: 10.18632/oncotarget.11124. Oncotarget. 2016. PMID: 27528023 Free PMC article.

8

Th17 cells in human disease.

Tesmer LA, Lundy SK, Sarkar S, Fox DA. Tesmer LA, et al. Among authors: lundy sk. Immunol Rev. 2008 Jun;223:87-113. doi: 10.1111/j.1600-065X.2008.00628.x. Immunol Rev. 2008. PMID: 18613831 Free PMC article. Review.

9

Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10.

Klinker MW, Reed TJ, Fox DA, Lundy SK. Klinker MW, et al. Among authors: lundy sk. PLoS One. 2013 Aug 5;8(8):e70131. doi: 10.1371/journal.pone.0070131. Print 2013. PLoS One. 2013. PMID: 23940537 Free PMC article.

10

Immune Cell Infiltration into the Eye Is Controlled by IL-10 in Recoverin-Induced Autoimmune Retinopathy.

Nikoopour E, Lin CM, Sheskey S, Heckenlively JR, Lundy SK. Nikoopour E, et al. Among authors: lundy sk. J Immunol. 2019 Feb 15;202(4):1057-1068. doi: 10.4049/jimmunol.1800574. Epub 2019 Jan 11. J Immunol. 2019. PMID: 30635390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters